Cardioversion
Cardioversion is a medical procedure with 12 clinical trials. Currently 1 active trials ongoing. Historical success rate of 71.4%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
71.4%
5 of 7 finished
28.6%
2 ended early
1
trials recruiting
12
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation
MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry
Bursa Postgraduate Hospital Department of Cardiology
Impact of New Biomarkers on Maintenance of Sinus Rhythm After Cardioversion or Ablation of Atrial Fibrillation
P-wave Terminal Force in Patients With Atrial Fibrillation.
Clinical Trials (12)
Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation
MANAGE-VT Registry - MANAGEment of Ventricular Tachycardia Outcomes Registry
Bursa Postgraduate Hospital Department of Cardiology
Impact of New Biomarkers on Maintenance of Sinus Rhythm After Cardioversion or Ablation of Atrial Fibrillation
P-wave Terminal Force in Patients With Atrial Fibrillation.
Atrial Fibrillation Recurrence Following Cardioversion: the Role of Clinical Factors and Alpha Defensin Levels
Renal Function Post Cardioversion for Atrial Fibrillation
Safety of External Electrocardioversion in Device Patients
Combined Amiodarone and Electrical Cardioversion for Postoperative Atrial Fibrillation After Cardiac Surgery
Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF
Inflammation as a Predictor in Cardioversion of Atrial Fibrillation
Study of the Effect of Cardioversion on Cardiac Volume in Patients With Persistent Atrial Fibrillation
All 12 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 12